Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Exploratory Study of Patient-derived Organoids for the Prediction and Evaluation of Clinical Efficiency Effect of Colorectal Cancer Liver Metastasis

NCT05183425 is registered in ClinicalTrials.gov with Changhai Hospital as lead sponsor.

NCT NCT05183425
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05183425 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Exploratory Study of Patient-derived Organoids for the Prediction and Evaluation of Clinical Efficiency Effect of Colorectal Cancer Liver Metastasis
Lead sponsor
Changhai Hospital
Phase
Observational
Overall status
Unknown status
Start date
January 1, 2022
Completion date
December 31, 2024
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

explore the consistency of drug sensitivity between primary colorectal cancer and liver metastases